Moffitt’s Radiation Oncology Department will utilize Cvergenx’s Genomic-Adjusted Radiation Dose (GARD) model.
9-Aug-2017 11:05 AM EDT Add to Favorites
Precision medicine has become the leading innovation of cancer treatment. Patients are routinely treated with drugs that are designed to target specific tumors and molecules. Despite the progress that has been made in targeted cancer therapies, the...
3-Aug-2017 11:05 AM EDT Add to Favorites
Radiation Therapy Prior to Surgery Reduces the Risk of Secondary Tumors in Early-Stage Breast Cancer Patients
Moffitt researchers launched a first of its kind study comparing the long-term benefits of radiation therapy in women with breast cancer either before surgery or after surgery. Their study found that patients who have neoadjuvant radiation therapy...
17-Jul-2017 9:05 AM EDT Add to Favorites
The investigation found that the drug, geranylgeranyltransferase inhibitor GGTI-2418 suppresses a new defective PTEN cancer pathway discovered by Pagano’s group.
14-Jun-2017 1:45 PM EDT Add to Favorites
Peter Kanetsky, Ph.D., M.P.H., chair of the Cancer Epidemiology Department at Moffitt Cancer Center, and colleagues from the International TEsticular CAncer Consortium (TECAC), launched a large analysis of five major testicular cancer studies to...
13-Jun-2017 9:05 AM EDT Add to Favorites
Moffitt Researchers Identify a Novel Inhibitor That Overcomes the Drug Resistance in Prostate Cancer
In a study published today in Cancer Cell, Moffitt Cancer Center researchers report that a newly discovered epigenetic mechanism can lead to the development of castration-resistant prostate cancer. They identified a novel drug that targets this...
12-Jun-2017 12:05 PM EDT Add to Favorites
Moffitt Develops Innovative Approaches to Improve Personalized Radiation Therapy for Head and Neck Cancer Patients
Moffitt researchers have developed a test called the radiosensitivity index that determines how sensitive a patient’s tumor is to radiation therapy. The radiosensitivity index is based on the expression of different genes in a patient’s tumor...
31-May-2017 10:05 AM EDT Add to Favorites
Moffitt Researchers Demonstrate Mathematical Modeling Can Identify Ways to Limit Aggressive Tumor Cell Growth
Researchers in the Integrated Mathematical Oncology Department at Moffitt Cancer Center recent study found that mathematical models can be used to predict how different tumor cell populations interact with each other and respond to a changing...
24-May-2017 8:05 AM EDT Add to Favorites